Antithrombotic Properties of SSR182289A, a New, Orally Active Thrombin Inhibitor
J Lorrain(Sanofi (France)), Stephen E. O'Connor(Sanofi (France)), Catherine Berry(Sanofi (France)), C. Visconte, P Ferrari, L. Millet(Sanofi (France)), Irène Lechaire, Catherine Lunven(Sanofi (France)), Paul Schaeffer(Universidad La Salle), Sylvette Lochot, J‐M. Herbert, M. Sainte-Marie
Cited by 23
Related Papers
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|943
PGC-1α Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERRα: a Mechanism for Transcriptional Control of Muscle Glucose Metabolism
|Molecular and Cellular Biology|2005|355
The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways
|The Journal of Experimental Medicine|2002|349
Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart
|Genes & Development|2008|325
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy
|Journal of Clinical Investigation|2005|260